Better Health - September 2021

Page 1

Steven Wright to play Northampton in early 2022, see masslive.com/entertainment

Better Health D

BENEFITS OF AN AGENCY: Behavioral Health Network, D2 FALL MOVIES: Films coming to theaters, streaming services, D5 THE NEW YORK TIMES SUNDAY CROSSWORD, D8

| SUNDAY, SEPTEMBER 19, 2021

|

Behavioral Health Transcranial magnetic stimulation is a brain neuromodulation treatment that has become more readily available in recent years. It is used for the treatment of clinical depression that has failed standard treatment or when the patient is unable to tolerate standard approaches.

By Cori Urban

non-invasive brain modulation treatment called TMS,” Ackerman pointed out. There is about a 12 percent Transcranial magnetic risk of suffering from a serious stimulation is a brain neurodepressive episode during a modulation treatment that person’s lifetime. “The illness of depression is has become more readily relatively common and has a available in recent years. It prevalence of approximately 7 is used for the treatment of percent each year in the Unit- clinical depression that has failed standard treatment or ed States population,” noted Dr. Tedd Ackerman, medical when the patient is unable to director of behavioral health tolerate standard approaches. A candidate for TMS generat Holyoke Medical Center. “Clinical depression is a seri- ally would have tried a comous cause of disability and is bination of medication and psychotherapy. “People may also a significant contributor to mortality.” often wish to try TMS prior to electroconvulsive therapy, Clinical depression unlike common sadness is a conwhich is a much more invasive procedure that involves andition marked by ongoing esthesia; TMS does not,” said combination of symptoms including sadness, inability to Ackerman, who has found it experience pleasure, fatigue, to be a personally rewarding concentration problems and experience to be able to offer people who are suffering a thoughts of self-harm. It affects mood, thinking patterns new, non-invasive modality. and biology. Holyoke Medical Center began offering TMS services “It is different from common sadness that everyone in 2017. experiences,” Ackerman said. The treatment is said to feel “It can have pervasive effects like a series of tapping sensaon one’s relationships, work tions with periods of rest in life and health. It tends to be a between, for a total number of recurrent condition. Unforapproximately 3,000 pulses per treatment. tunately, clinical depression The patient is awake and tends to go undiagnosed and alert during the treatments, untreated.” But once diagnosed, it can which last just more than half an hour. The person is seated be treated. Initial treatment for clinical in a comfortable treatment depression is usually psycho- chair with a small headband therapy or medication, but affixed to the forehead with the magnets resting on the some trials have indicated that a combination of both is head. more effective. The patient can return to normal daily activities after “One of the exciting develtreatment. opments in psychiatry over Once daily treatment is the past number of years has complete, there will be six been the development of Special To The Republican

ibuprofen. “At Holyoke Medical Center we do everything we can to insure someone’s comfort during treatment,” Ackerman said. This may include changing the parameters of treatment or alternating where the magnetic coil is placed, a procedure called remapping. The magnet is about the size of a carton of milk, and the patient is not enclosed during treatment. The magnetic field strength is generally about the same as what is involved in an MRI device. “Neuro imaging of depressed patients shows decreased functioning in the left pre-frontal part of the brain; TMS tries to target this area,” Ackerman said. “It is thought that the mechanism of action involves changing brain cortical activity that connects to other areas of the brain, which ultimately increases neuro transmitter turnover and may normalize hypothalamic pituitary functioning that is often abnormally functioning in patients with clinical depression.” TMS is FDA-cleared to treat depression. Massachusetts insurances are covering TMS when criteria are met. Holyoke Medical Center Above: Dr. Tedd Ackerman stands next to the TMS chair at can treat up to 10 patients Holyoke Medical Center. (PHOTO COURTESY OF HMC) each day, operating 52 weeks a year. Treatments are five days a week except on major remission.” This is somewhat ment,” Ackerman said. holidays. Common side effects inhigher than in some initial “TMS is a safe, generally clude superficial scalp pain at studies. well-tolerated treatment for the site of treatment and ocStaff at the medical center has treated 277 patients since casional headache. Headache clinical depression that has not responded to standard and scalp pain are usually TMS was introduced there. self-limiting and may be alle- treatment. It has significantly Prior to the availability of viated by the use of Tylenol or improved numerous patients’ TMS at Holyoke Medical taper visits scheduled to gradually reduce the need for regular treatments. Improvement is often seen after 15-20 treatments, but may take longer with some patients. “Generally, at Holyoke Medical Center our response rate to TMS has been 66 percent having a significant response with improved quality of life,” Ackerman said. “Approximately 33 percent of the patients have achieved

Center, patients would have a psychiatric evaluation to confirm the diagnosis and whether or not there were any contraindications to treatment with TMS. These contraindications include implanted metallic hardware in the brain such as aneurysm clips, implanted electrical devices such as pacemakers or cochlear implants. “TMS is generally safe and well tolerated, and very few patients drop out of treat-

lives since we have started treating it at Holyoke Medical Center,” Ackerman said. “It gives patients an additional treatment beyond standard medication and psychotherapy.” Holyoke Medical Center staff will work with a patient’s current medical/psychiatric provider to see if TMS is an appropriate option. “Since depression can recur if TMS is effective, retreatment with TMS is often highly effective,” Ackerman said. Some people also find that medications, which previously were not effective, may be more helpful after treatment. TMS is being investigated for other psychiatric conditions including post-traumatic stress disorder, obsessive-compulsive disorder, adolescent depression, bipolar depression and neuromodulation post stroke. “There are also areas of investigation to try and reduce the time of treatment. These are exciting areas of research,” Ackerman said. If TMS is not beneficial in treating the person’s depression, other options to explore would include electroconvulsive therapy — which is offered at Holyoke Medical Center — and the medication Esketamine, a relatively newer option for depression resistant to treatment. Ask your doctor for more information or for more information, go online to holyokehealth.com/tms or call 413-535-4930.

Transcranial Magnetic Stimulation Therapy 413.535.4930 • holyokehealth.com/tms


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.